Neurosoft Bioelectronics
About
Technology stack
detected 2026-07-04
AWSNo comments yet. Be the first to share your take.
What does Neurosoft Bioelectronics do?
Neurosoft Bioelectronics is a startup focused on creating advanced brain-computer interface (BCI) technology. Their core innovation lies in developing soft and stretchable BCI platforms designed for seamless integration with the brain. The company recently secured a $7.5 million oversubscribed seed funding round to accelerate the scaling of its technology.
How much funding has Neurosoft Bioelectronics raised?
Neurosoft Bioelectronics has raised a total of $8M in funding. The most recent round on record is Seed.
Where is Neurosoft Bioelectronics headquartered?
Neurosoft Bioelectronics is headquartered in Geneva, Switzerland.
When was Neurosoft Bioelectronics founded?
Neurosoft Bioelectronics was founded in 2021.
What industry does Neurosoft Bioelectronics operate in?
Neurosoft Bioelectronics operates in Biotechnology, Medical Devices, Neurotechnology, Artificial Intelligence, Neurotech & HCI, Brain-Computer Interface.
How many employees does Neurosoft Bioelectronics have?
Neurosoft Bioelectronics has approximately 18 people on record.
What is Neurosoft Bioelectronics's revenue?
StartupHub estimates Neurosoft Bioelectronics's annual revenue at $2.3M (range $1.2M to $6.9M, 71% confidence), based on comparable companies in the sector.
What is Neurosoft Bioelectronics's valuation?
StartupHub estimates Neurosoft Bioelectronics's effective valuation at $28.7M (range $18.8M to $45.0M, 11% confidence), based on comparable companies in the sector.